Amberen®, a leading brand in symptom relief innovation supporting all phases of menopause, has officially announced the launch of Amberen ENERGY MOOD SLEEP, which...
StemCyte has officially announced a significant breakthrough in its Phase IIa clinical trial of HPC, Cord Blood (HPC, CB) for treating Post-COVID Syndrome (Long...
Fullpower Technologies, in collaboration with Stanford Sleep Medicine and UCSF Department of Psychiatry and Behavioral Sciences, has officially presented two new studies at the...
Research Solutions, a trusted provider of cloud-based workflow solutions to accelerate research for R&D-driven organizations, has officially announced the launch of a new Clinical...
